Alpha 2.0
Login Register
» Authors » Mark Dovey

Mark Dovey

Explore the profile of Mark Dovey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 219
Followers 0
Related Specialties
Pediatrics
Critical Care
Pulmonary Medicine
Top 10 Co-Authors
Robert Gerstle
Henry L Dorkin
Anne Marie Comeau
Brian P OSullivan
Kenan Haver
Roger B Eaton
David A Waltz
Ronald L Gibson
Sharon McNamara
Tom Martin
Published In
J Pediatr
Am J Respir Crit Care Med
Chest
Pediatrics
Affiliations
Soon will be listed here.
Recent Articles
1.
Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study
Dovey M, Aitken M, Emerson J, McNamara S, Waltz D, Gibson R
Chest . 2007 Jul; 132(4):1212-8. PMID: 17646219
Background: We hypothesized that adding 5 days of prednisone to standard therapy for acute pulmonary exacerbations in patients with cystic fibrosis (CF) would result in a more rapid and greater...
2.
Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis
Kalish L, Waltz D, Dovey M, Potter-Bynoe G, McAdam A, LiPuma J, et al.
Am J Respir Crit Care Med . 2005 Nov; 173(4):421-5. PMID: 16272450
Rationale: Chronic infection with Burkholderia cepacia complex bacteria in cystic fibrosis is associated with accelerated decline in pulmonary function and increased mortality. Clinical implications of the recently characterized genomovar VI,...
3.
Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result
Marie Comeau A, Parad R, Gerstle R, OSullivan B, Dorkin H, Dovey M, et al.
J Pediatr . 2005 Oct; 147(3 Suppl):S98-100. PMID: 16202793
Objective: To evaluate compliance with recommendations for sweat testing/specialty evaluation and genetic counseling after a positive cystic fibrosis newborn screening (CF NBS) result. Study Design: All infants with positive CF...
4.
Challenges in implementing a successful newborn cystic fibrosis screening program
Marie Comeau A, Parad R, Gerstle R, OSullivan B, Dorkin H, Dovey M, et al.
J Pediatr . 2005 Oct; 147(3 Suppl):S89-93. PMID: 16202791
Objective: To identify necessary components of a successful cystic fibrosis (CF) newborn screening (NBS) program. Study Design: The approach to CF NBS used by the Massachusetts NBS program was examined....
5.
Sweat testing infants detected by cystic fibrosis newborn screening
Parad R, Marie Comeau A, Dorkin H, Dovey M, Gerstle R, Martin T, et al.
J Pediatr . 2005 Oct; 147(3 Suppl):S69-72. PMID: 16202787
Objective: Describe and define limitations of early pilocarpine iontophoresis (sweat testing) for cystic fibrosis (CF) newborn screening (NBS). Study Design: Population-based results from follow-up of CF NBS-positive newborns. Results: Insufficient...
6.
Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections
Marie Comeau A, Parad R, Dorkin H, Dovey M, Gerstle R, Haver K, et al.
Pediatrics . 2004 Jun; 113(6):1573-81. PMID: 15173476
Objectives: Newborn screening for cystic fibrosis (CF) provides a model to investigate the implications of applying multiple-mutation DNA testing in screening for any disorder in a pediatric population-based setting, where...
7.
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis
Gibson R, Emerson J, McNamara S, Burns J, Rosenfeld M, Yunker A, et al.
Am J Respir Crit Care Med . 2002 Dec; 167(6):841-9. PMID: 12480612
We conducted a double-blind, placebo-controlled, multicenter, randomized trial to test the hypothesis that 300 mg of tobramycin solution for inhalation administered twice daily for 28 days would be safe and...